| S.NO | Generic name | Composition | PH . | Strength |
| Ref. | ||||
| 1 | Levocetirizine Tablets IP | Each film coated tablet contains: | ||
| Levocetirizine Hydrochloride | IP | 10 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 2 | Diclofenac Potassium, | Each uncoated tablet contains: | ||
| Paracetamol & | Diclofenac Potassium | BP | 50 mg | |
| Chlorzoxazone Tablets | Paracetamol | IP | 325 mg | |
| Chlorzoxazone | USP | 250 mg | ||
| Excipients | qs | |||
| 3 | Diclofenac Sodium & | Each uncoated tablet contains: | ||
| Paracetamol Tablets IP | Diclofenac Sodium | IP | 50 mg | |
| Paracetamol | IP | 325 mg | ||
| Excipients | qs | |||
| 4 | Aceclofenac , | Each uncoated tablet contains: | ||
| Paracetamol & | Aceclofenac | IP | 100 mg | |
| Chlorzoxazone Tablets | Paracetamol | IP | 325 mg | |
| Chlorzoxazone | USP | 250 mg | ||
| Excipients | qs | |||
| 5 | Telmisartan Tablets IP | Each uncoated tablet contains: | ||
| Telmisartan | IP | 40 mg | ||
| Excipients | qs | |||
| 6 | Telmisartan & | Each uncoated tablet contains: | ||
| Hydrochlorothiazide | Telmisartan | IP | 40 mg | |
| Tablets IP | Hydrochlorothiazide | IP | 12.5 mg | |
| Excipients | qs | |||
| 7 | Fluconazole Tablets IP | Each uncoated tablet contains: | ||
| Fluconazole | IP | 50 mg | ||
| Excipients | qs | |||
| 8 | Losartan Potassium | Each film coated tablet contains: | ||
| Tablets I.P (50 mg) | Losartan Potassium | IP | 50 mg | |
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 9 | Losartan Potassium | Each film coated tablet contains: | ||
| & Amlodipine Tablets IP | Losartan Potassium | IP | 50 mg | |
| Amlodipine Besilate | IP | |||
| eq .to Amlodipine | 5 mg | |||
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 10 | Losartan Potassium | Each film coated tablet contains: | ||
| & Hydrochlrothiazide | Losartan Potassium | IP | 50 mg | |
| Tablets IP | Hydrochlrothiazide | IP | 12.5 mg | |
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 11 | Atorvastatin | Each film coated tablets contains : | ||
| Tablets IP (10 mg) | Atorvastatin Calcium | IP | ||
| eq. to Atorvastatin | 10 mg | |||
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 12 | Atorvastatin | Each film coated tablets contains : | ||
| Tablets IP (20 mg) | Atorvastatin Calcium | IP | ||
| eq. to Atorvastatin | 20 mg | |||
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 13 | Atorvastatin | Each film coated tablets contains : | ||
| Tablets IP (40 mg) | Atorvastatin Calcium | IP | ||
| eq. to Atorvastatin | 40 mg | |||
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 14 | Olmesartan | Each film coated tablet contains: | ||
| Medoxomil Tablets IP | Olmesartan Medoxomil | IP | 20 mg | |
| (20 mg) | Excipients | qs | ||
| Approved colour shall be used | ||||
| 15 | Olmesartan | Each film coated tablet contains: | ||
| Medoxomil Tablets IP | Olmesartan Medoxomil | IP | 40 mg | |
| (40 mg) | Excipients | qs | ||
| (Approved colour shall be used) | ||||
| 16 | Ramipril Tablets IP | Each uncoated tablet contains: | ||
| (1.25 mg) | Ramipril | IP | 1.25 mg | |
| Excipients | qs | |||
| 17 | Ramipril Tablets IP | Each uncoated tablet contains: | ||
| (2.5 mg) | Ramipril | IP | 2.5 mg | |
| Excipients | qs | |||
| 18 | Ramipril Tablets IP | Each uncoated tablet contains: | ||
| (5 mg) | Ramipril | IP | 5 mg | |
| Excipients | qs | |||
| 19 | Montelukast & | Each film coated tablet contains: | ||
| Fexofenadine | Montelukast Sodium | IP | ||
| Hydrochloride | eq.to Montelukast | 10 mg | ||
| Tablets | Fexofenadine Hydrochloride | IP | 120 mg | |
| Excipients | qs | |||
| (Approved colour shall be used) | ||||
| 20 | Amlodipine & | Each uncoated tablet contains: | ||
| Atenolol Tablets | Amlodipine Besilate | IP | ||
| eq.to Amlodipine | 5 mg | |||
| Atenolol | IP | 50 mg | ||
| Excipients | qs | |||
| 21 | Olmesartan | Each film coated tablet contains: | ||
| Medoxomil & | Olmesartan Medoxomil | IP | 20 mg | |
| Hydrochlrothiazide | Hydrochlrothiazide | IP | 12.5 mg | |
| Tablets IP | Excipients | qs | ||
| (Approved colour shall be used) | ||||
| 22 | Olmesartan | Each film coated tablet contains: | ||
| Medoxomil & | Olmesartan Medoxomil | IP | 40 mg | |
| Hydrochlrothiazide | Hydrochlrothiazide | IP | 12.5 mg | |
| Tablets IP | Excipients | qs | ||
| (Approved colour shall be used) | ||||
| 23 | Metformin Hydrochloride | Each uncoated tablet contains: | ||
| Prolonged-release & | Glimepiride | IP | 1 mg | |
| Glimepiride Tablets IP | Metformin Hydrochloride | IP | 500 mg | |
| ( In Prolonged- release form) | ||||
| Excipients | qs | |||
| 24 | Metformin Hydrochloride | Each uncoated tablet contains: | ||
| Prolonged-release & | Glimepiride | IP | 2 mg | |
| Glimepiride Tablets IP | Metformin Hydrochloride | IP | 500 mg | |
| ( In Prolonged- release form) | ||||
| Excipients | qs | |||
| 25 | Nimesulide & | Each uncoated tablet contains: | ||
| Paracetamol Tablets | Nimesulide | BP | 100 mg | |
| Paracetamol | IP | 325 mg | ||
| Not for use below 12 years of age | ||||
| 26 | Paracetamol Tablets | Each uncoated tablet contains: | ||
| IP (650 mg) | Paracetamol | IP | 650 mg | |
| Excipients | qs | |||
| 27 | Finasteride Tablets IP | Each uncoated tablet contains: | ||
| Finasteride | IP | 1 mg | ||
| Excipients | qs | |||
| 28 | Aceclofenac Tablets | Each uncoated tablet contains : | ||
| IP (100 mg) | Aceclofenac | IP | 100 mg | |
| Excipients | qs | |||
| 29 | Etoricoxib Tablets IP | Ecah film coated tablet contains: | ||
| (120 mg) | Etoricoxib | IP | 120 mg | |
| Approved colour Shall be used | ||||
| Excipients | qs | |||
| Approved colour Shall be used | ||||
| 30 | Methylprednisolone | Each uncoated tablet contains: | ||
| Tablets IP (8 mg) | Methylprednisolone | IP | 8 mg | |
| Excipients | qs | |||
| 31 | Methylprednisolone | Each uncoated tablet contains: | ||
| Tablets IP (4 mg) | Methylprednisolone | IP | 4 mg | |
| Excipients | qs | |||
| 32 | Methylprednisolone | Each uncoated tablet contains: | ||
| Tablets IP (16 mg) | Methylprednisolone | IP | 16 mg | |
| Excipients | ||||
| 33 | Glimepiride Tablets IP | Each uncoated tablet contains: | ||
| (1 mg) | Glimepiride | IP | 1 mg | |
| Excipients | qs | |||
| 34 | Glimepiride Tablets IP | Each uncoated tablet contains: | ||
| (2 mg) | Glimepiride | IP | 2 mg | |
| Excipients | qs | |||
| 35 | Isoxsuprine | Each uncoated sustained release tablet contains: | ||
| Hydrochloride | Isoxsuprine Hydrochloride | IP | 40 mg | |
| Sustained Release | Excipients | qs | ||
| Tablets | ||||
| 36 | Ciprofloxacin Tablets | Each film coated tablet contains: | ||
| IP (250 mg) | Ciprofloxacin Hydrochloride | IP | ||
| eq.to Ciprofloxacin | 250 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 37 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Ciprofloxacin Hydrochloride | IP | ||
| eq. to Ciprofloxacin | 500mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 38 | Paracetamol , | Each uncoated tablet contains: | ||
| Phenylephrine HCl | Paracetamol | IP | 325mg | |
| &Cetirizine HCl | Phenylephrine Hydrochloride | IP | 5mg | |
| Tablets | Cetirizine Hydrochloride | IP | 5mg | |
| Excipients | qs | |||
| 39 | Terbinafine Tablets IP | Each uncoated tablet contains: | ||
| (250 mg) | Terbinafine Hydrochloride | IP | ||
| eq to terbinafine | 250mg | |||
| Excipients | qs | |||
| 40 | Aceclofenac and | Each film coated tablet contains: | ||
| Thiocolchicoside | Aceclofenac | IP | 100mg | |
| Tablets | Thiocolchicoside | IP | 8mg | |
| Excipients | ||||
| Approved color shall be used | qs | |||
| 41 | Serratiopeptidase | Each film coated tablet contains: | ||
| Tablets IP (10 mg) | Serratiopeptidase | IP | 10mg | |
| (As enteric coated granules) | ||||
| Excipients | qs. | |||
| Approved color shall be used | ||||
| 42 | Telmisartan & | Each uncoated tablet contains: | ||
| Amlodipine Tablets IP | Telmisartan | IP | 40mg | |
| Amlodipine Besilate | IP | |||
| Eq. to Amlodipine | 5mg | |||
| Excipients | qs. | |||
| 43 | Nimesulide , | Each film coated tablet contains: | ||
| Paracetamol & | Nimesulide | BP | 100 mg | |
| Serratiopeptidase | Paracetamol | IP | 325 mg | |
| Tablets | Serratiopeptidease | IP | 15 mg | |
| (As enteric coated granules) | ||||
| Approved color shall be used | ||||
| (Not for use below 12 year of age) | ||||
| 44 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Levofloxacin Hemihydrate | IP | ||
| eq.to Levofloxacin | 500 mg | |||
| Excipients | qs. | |||
| Approved color shall be used | ||||
| 45 | Deflazacort Tablets | Each uncoated tablet contains: | ||
| Deflazacort | 30 mg | |||
| Excipients | qs | |||
| 46 | Aceclofenac , | Each film coated tablet contains: | ||
| Paracetamol & | Aceclofenac | IP | 100mg | |
| Serratiopeptidase | Paracetamol | IP | 325mg | |
| Tablets | Serratiopeptidease | IP | 15mg | |
| (As enteric coated granules) | ||||
| Approved colo shall be used | ||||
| 47 | Nimesulide , | Each uncoated bolus contains: | ||
| Paracetamol & | Nimesulide | BP | 500 mg | |
| Serratiopeptidase | Paracetamol | IP | 2.0 gm | |
| Bolus | Serratiopeptidease | IP | 50 mg | |
| (As enteric coated granules) | ||||
| (For veterinary use only) | ||||
| Excipients | qs | |||
| 48 | Diclofenac Sodium | Each film coated tablet contains: | ||
| Tablets IP | Diclofenac Sodium | IP | 100 mg | |
| Excipients | qs | |||
| Approved color shall be used | ||||
| 49 | Diclofenac Potassium & | Each uncoated tablet contains: | ||
| Paracetamol | Diclofenac Potassium | BP | 50 mg | |
| Tablets | Paracetamol | IP | 325 mg | |
| Excipients | qs | |||
| Approved color shall be used | ||||
| 50 | Diclofenac Potassium , | Each film coated tablet contains: | ||
| Paracetamol & | Diclofenac Potassium | BP | 50 mg | |
| Serratiopeptidase | Paracetamol | IP | 325 mg | |
| Tablets | Serratiopeptidase | IP | 15 mg | |
| (As enteric coated granules) | ||||
| Excipients | qs | |||
| Approved color shall be used | ||||
| 51 | Ferrous Ascorbate , | Each film coated tablet contains: | ||
| Folic Acid & Zinc Sulphate | Ferrous Ascorbate | |||
| Tablets | eq.to elemental Iron | 100 mg | ||
| Folic Acid | IP | 1.5 mg | ||
| Zinc Sulphate monohydrate | IP | |||
| eq to elemental Zinc | 22.5 mg | |||
| Excipients | qs | |||
| Approved color shall be used | ||||
| 52 | Tramadol | Each uncoated tablet contains: | ||
| Hydrochloride & | Tramadol Hydrochloride | IP | 37.5 mg | |
| Paracetamol Tablets | Paracetamol | IP | 325 mg | |
| Excipients | qs | |||
| 53 | Ondansetron Hydrochloride | Each uncoated tablet contains: | ||
| Tablets IP (8 mg) | Ondansetron Hydrochloride | IP | ||
| eq.to Ondansetron | 8 mg | |||
| Excipients | qs | |||
| 54 | Aceclofenac & | Each film coated tablet contains: | ||
| Thiocolchicoside Tablets | Aceclofenac | IP | 100mg | |
| Thiocolchicoside | IP | 4 mg | ||
| Excipients | qs | |||
| Approved color shall be used | ||||
| 55 | Trioxsalen Tablets | Each film coated tablet contains: | ||
| Trioxsalen | USP | 25 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 56 | Fluconazole Tablets IP | Each Uncoated tablet conains: | ||
| Fluconazole | IP | 150 mg | ||
| 57 | Mefenamic Acid | Each uncoated tablet contains: | ||
| Dicyclomine HCl Tablets | Mefenamic Acid | IP | 250 mg | |
| Dicyclomine Hydrochloride | IP | 20 mg | ||
| Excipients | qs | |||
| 58 | Deflazacort Tablets | Each uncoated tablet contains: | ||
| Deflazacort | 6 mg | |||
| Excipients | qs | |||
| 59 | Fexofenadine HCl Tablets IP | Each film coated tablet contains: | ||
| Fexofenadine Hydrochloride | IP | 180 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 60 | Cinnarizine & | Each uncoated tablet contains: | ||
| Domperidone Tablets | Cinnarizine | IP | 20 mg | |
| Domperidone | IP | 15 mg | ||
| Excipients | qs | |||
| 61 | Ciprofloxacin & | Each film coated tablet contains: | ||
| Tinidazole Tablets | Ciprofloxacin Hydrochloride | IP | ||
| eq. to Ciprofloxacin | 500mg | |||
| Tinidazole | IP | 600 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 62 | Levocetirizine | Each film coated tablet contains: | ||
| Hydrochloride & | Levocetirizine Hydrochloride | IP | 5 mg | |
| Ambroxol Hydrochloride | Ambroxol Hydrochloride | IP | 60 mg | |
| Tablets | Excipients | qs | ||
| 63 | Aceclofenac & | Each film coated tablet contains: | ||
| Serratiopeptidase | Aceclofenac | IP | 100 mg | |
| Tablets | Serratiopeptidase | IP | 10 mg | |
| (as enteric coated granules) | ||||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 64 | Ferrous Ascorbate & | Each film coated tablet contains: | ||
| Folic Acid Tablets | Ferrous Ascorbate | |||
| eq.to Elemental Iron | 100 mg | |||
| Folic Acid | IP | 1.5 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 65 | Biotin Tablets | Each film coated tablet contains: | ||
| Biotin | USP | 5 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 66 | Doxylamine Succinate, | Each enteric coated tablet contains: | ||
| Pyridoxine HCl & | Doxylamine Succinate | USP | 10 mg | |
| Folic Acid Tablets | Pyridoxine Hydrochloride | IP | 10 mg | |
| Folic Acid | IP | 2.5 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 67 | Doxofylline Tablets | Each film coated tablet contains: | ||
| IP (400 mg) | Doxofylline | IP | 400 mg | |
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 68 | Methylcobalamin & | Each film coated tablet contains: | ||
| Gabapentin Tablets | Methylcobalamin | IP | 500 mcg | |
| Gabapentin | IP | 300 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 69 | Calcium Citrate , | Each film coated tablet contains: | ||
| Folic Acid & | Calcium Citrate Maleate | |||
| Vitamin D3 Tablets | eq. to Elemental Calcium | 250 mg | ||
| Folic Acid | IP | 50 mcg | ||
| Vitamin D3 | IP | 100 I.U. | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 70 | Metoprolol Tartrate | Each film coated tablet contains: | ||
| Tablets IP (25 mg) | Metoprolol Tartrate | IP | 25 mg | |
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 71 | Dothiepin Tablets IP (75 mg) | Each film coated tablet contains: | ||
| Dothiepin Hydrochloride | IP | 75 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 72 | Tolperisone | Each film coated tablet contains: | ||
| Hydrochloride | Tolperisone Hydrochloride | 150 mg | ||
| Tablets | Excipients | qs | ||
| Approved colour shall be used | ||||
| 73 | Mefenamic Acid & | Each uncoated tablet contains: | ||
| Paracetamol Tablets | Mefenamic Acid | IP | 450 mg | |
| Paracetamol | IP | 325 mg | ||
| Excipients | qs | |||
| 74 | Albendazole | Each chewable tablet contains: | ||
| Tablets I.P | Albendazole | IP | 400mg | |
| Excipients | qs | |||
| 75 | Loratadine Tablets USP | Each uncoated tablet contains: | ||
| Loratadine | USP | 10 mg | ||
| Excipients | qs | |||
| 76 | Paracetamol & | Each uncoated tablet contains: | ||
| Domperidone Tablets | Paracetamol | IP | 325 mg | |
| Domperidone | IP | 20 mg | ||
| Excipients | qs | |||
| 77 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||
| (250 mg) | Levofloxacin Hemihydrate | IP | ||
| eq.to Levofloxacin | 250 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 78 | Levocetirizine | Each uncoated tablet contains: | ||
| Hydrochloride & | Levocetirizine Hydrochloride | IP | 2.5 mg | |
| Montelukast Sodium | Montelukast Sodium | IP | ||
| Tablets IP | eq.to Montelukast | 4 mg | ||
| Excipients | qs | |||
| 79 | Metoprolol Tartrate & | Each uncoated tablet contains: | ||
| Amlodipne Tablets | Metoprolol Tartrate | IP | 50 mg | |
| Amlodipne Besilate | IP | |||
| eq.to Amlodipine | 5 mg | |||
| Excipients | qs | |||
| 80 | Serratiopeptidase Tablets IP | Each film coated tablet contains: | ||
| (10 mg) | Serratiopeptidase | IP | 10 mg | |
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 81 | Diclofenac Potassium & | Each enteric coated tablet contains: | ||
| Serratiopeptidase Tablets | Diclofenac Potassium | BP | 50 mg | |
| Serratiopeptidase | IP | 10 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 82 | Ethamsylate Tablets | Each uncoated tablet contains: | ||
| Ethamsylate | BP | 500 mg | ||
| Excipients | qs | |||
| 83 | Diclofenac Potassium , | Each film coated tablet contains: | ||
| Paracetamol & | Diclofenac Potassium | BP | 50 mg | |
| Serratiopeptidase | Paracetamol | IP | 325 mg | |
| Tablets | Serratiopeptidase | IP | 10 mg | |
| (As enteric coated granules) | ||||
| Approved colour shall be used | ||||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 84 | Aceclofenac , | Each film coated tablet contains: | ||
| Paracetamol & | Aceclofenac | IP | 100 mg | |
| Serratiopeptidase | Paracetamol | IP | 325 mg | |
| Tablets | Serratiopeptidase | IP | 10 mg | |
| (As enteric coated granules) | ||||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 85 | Cefixime | Each uncoated dispersible tablet contains : | ||
| Dispersible | Cefixime | IP | ||
| Tablets IP (50 mg) | Cefixime | 50 mg | ||
| Excipients | qs | |||
| 86 | Drotaverine Hydrochloride | Each film coated tablet contains | ||
| & Mefenamic Acid Tablets | Drotaverine Hydrochloride | IP | 80 mg | |
| Mefenamic Acid | IP | 250 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 87 | Calcium Citrate, | Each uncoated tablet contains: | ||
| Magnesium Hydroxide , | Calcium Citrate | USP | ||
| Zinc Sulphate & | eq. to Elemental Calcium | 200mg | ||
| Vitamin D3 Tablets | Magnesium Hydroxide | IP | ||
| eq. to Elemental Magensium | 100mg | |||
| Zinc Sulphate | IP | |||
| eq. to Elemental Zinc | 4mg | |||
| Vitamin D3 | IP | 200 I.U | ||
| Excipients | q.s | |||
| 88 | Folic Acid Tablets IP | Each uncoated tablets contains : | ||
| Folic Acid | IP | 5 mg | ||
| Excipients | qs | |||
| 89 | Cefpodoxime | Each uncoated dispersible tablet contains : | ||
| Dispersible | Cefpodoxime Proxetil | IP | ||
| Tablets (50 mg) | Eq. to Cefpodoxime | 50 mg | ||
| Excipients | qs | |||
| 90 | Cefixime & Lactic Acid | Each film coated tablet contains : | ||
| Bacillus Tablets | Cefixime | IP | ||
| eq. to cefixime ( Anhydrous) | 200 mg | |||
| Lactic Acid Bacillus | 60 million spores | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 91 | Calcium Carbonate, | Each film caoted tablet contains: | ||
| Calcitriol & Zinc Tablets | Calcium Carbonate | IP | ||
| (oyster Shell) | ||||
| eq.to elemental Calcium | 500 mg | |||
| Calcitriol | IP | 0.25 mcg | ||
| Zinc Sulphate Monohydrate | IP | |||
| eq .to elemental Zinc | 7.5 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 92 | Pantoprazole Sodium & | Each enteric coated tablet contains: | ||
| Domperidone Tablets | Pantoprazole Sodium | IP | ||
| eq.to Pantoprazole | 20 mg | |||
| Domperidone | IP | 10 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 93 | Drotaverine HCl & | Each uncoated tablet contains: | ||
| Mefenamic Acid | Drotaverine Hydrochloride | IP | 40 mg | |
| Tablets | Mefenamic Acid | IP | 250 mg | |
| Excipients | qs | |||
| 94 | Drotaverine HCl & | Each uncoated tablet contains: | ||
| Mefenamic Acid | Drotaverine Hydrochloride | IP | 80 mg | |
| Tablets | Mefenamic Acid | IP | 250 mg | |
| Excipients | qs | |||
| 95 | Biotin | Each film coated tablet contains: | ||
| Calcium Pantothenate | Biotin | BP | 10mg | |
| Acetyl Cysteine | Calcium Pantothenate | IP | 100mg | |
| Sodium selenite | Acetyl Cysteine | USP | 50mg | |
| Cupric Oxide | Sodium selenite | USP | ||
| Zinc oxide Tablets | eq. to elemental Selenium | 65mcg | ||
| Cupric Oxide | ||||
| eq. to elemental copper | 3.0mg | |||
| Zinc oxide | IP | 22.5mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 96 | Paracetamol & | Each uncoated tablet contains: | ||
| Dicyclomine HCl | Paracetamol | I.P | 325mg | |
| Tablets | Dicyclomine Hydrochloride | I.P | 20mg | |
| Excipients | qs | |||
| 97 | Paracetamol & | Each uncoated tablet contains: | ||
| Caffeine tablets IP | Paracetamol | IP | 325mg | |
| Caffeine(anhydrous) | IP | 50mg | ||
| Excipients | q.s | |||
| 98 | Calcium Citrate, | Each film coated tablet contains: | ||
| Vitamin D3, | Calcium Citrate | USP | 1000mg | |
| Zinc Sulphate & | Vitamin D3 | IP | 200 IU | |
| Magnesium Hydroxide | Zinc Sulphate | IP | 15mg | |
| Tablets | eq. to Elemental Zinc | 4mg | ||
| Magnesium Hydroxide | IP | 250mg | ||
| eq.to elemental Magnesium | 100 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 99 | Levosulpiride Tablets | Each film coated tablet contains: | ||
| (25 mg) | Levosulpiride | 25mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 100 | Alfacalcidol & Calcium | Each film coated tablet contains: | ||
| Carbonate Tablets | Calcium Carbonate | IP | 500 mg | |
| (from as organic source of oyster shell) | ||||
| eq.to elemental Calcium | 200 mg | |||
| Alfacalcidol | IP | 0.25 mcg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 101 | Olmesartan & | Each uncoated tablet contains: | ||
| Amlodipine Tablets | Olmesartan Medoxomil | IP | 40 mg | |
| Amlodipine Besilate | IP | |||
| eq.to amlodipine | 5 mg | |||
| Excipients | q.s | |||
| 102 | Nimesulide dispersible | Each uncoated dispersible tablet contains: | ||
| Tablets (100 mg) | Nimesulide | BP | 100 mg | |
| Excipients | q.s | |||
| 103 | Biotin Tablets (10 mg) | Each film coated tablet contains: | ||
| Biotin | USP | 10 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 104 | Diclofenac Sodium , | Each uncoated tablet contains: | ||
| Paracetamol & | Diclofenac Sodium | IP | 50 mg | |
| Chlorozoxazone Tablets | Paracetamol | IP | 325 mg | |
| Chlorozoxazone | IP | 250 mg | ||
| Excipients | q.s | |||
| 105 | Calcium ,Vitamin D3 & | Each film coated tablet contains: | ||
| Folic Acid Tablets | Calcium Citrate Maleate | |||
| eq.to elemental Calcium | 250 mg | |||
| Vitamin D3 | IP | 100 I.U | ||
| Folic Acid | IP | 50 mcg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 106 | Aceclofenac & | Each film coated tablet contains: | ||
| Serratiopeptidase | Aceclofenac | IP | 100 mg | |
| Tablets | Serratiopeptidase | IP | 15 mg | |
| (As enteric coated Granules) | ||||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 107 | Calcium Citrate Maleate , | Each film coated tablet contains: | ||
| Magnesium Hydroxide , | Calcium Citrate Maleate | |||
| Zinc & Vitamin D3 | eq.to elemental Calcium | 200 mg | ||
| Tablets | Magnesium Hydroxide | IP | ||
| eq.to elemental magnesium | 100 mg | |||
| Zinc Sulphate | IP | |||
| eq.to Elemental Zinc | 4 mg | |||
| Vitamin D3 | IP | 200 I.U. | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 108 | Paracetamol Tablets IP | Each uncoated tablet contains: | ||
| Paracetamol | IP | 500mg | ||
| Excipients | qs | |||
| 109 | Hydroxyzine | Each film coated tablet contains: | ||
| Hydrochloride | Hydroxyzine Hydrochloride | IP | 25mg | |
| Tablets IP | Excipients | qs | ||
| Approved colour shall be used | ||||
| 110 | Telmisartan Tablets IP | Each uncoated tablet contains: | ||
| (20 mg) | Telmisartan | IP | 20mg | |
| Excipients | qs | |||
| 111 | Telmisartan Tablets IP | Each uncoated tablet contains: | ||
| (80 mg) | Telmisartan | IP | 80mg | |
| Excipients | qs | |||
| 112 | Ondansetron | Each uncoated tablet contains: | ||
| Hydrochloride | Ondansetron Hydrochloride | IP | ||
| Tablets IP (4 mg) | eq. to Ondansetron | 4mg | ||
| Excipients | qs | |||
| 113 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||
| (400 mg) | Ofloxacin | IP | 400mg | |
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 114 | Allopurinol Tablets IP | Each uncoated tablet contains: | ||
| (100 mg) | Allopurinol | IP | 100mg | |
| Excipients | qs | |||
| 115 | Allopurinol Tablets IP | Each uncoated tablet contains: | ||
| (300 mg) | Allopurinol | IP | 300mg | |
| Excipients | qs | |||
| 116 | Roxithromycin Tablets | Each film coated tablet contains: | ||
| IP (150 mg) | Roxithromycin | IP | 150mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 117 | Cinnarizine Tablets IP | Each uncoated tablet contains: | ||
| (25 mg) | Cinnarizine | IP | 25mg | |
| Excipients | q.s | |||
| 118 | Cinnarizine Tablets IP | Each uncoated tablet contains: | ||
| (75 mg) | Cinnarizine | IP | 75mg | |
| Excipients | q.s | |||
| 119 | Enalapril Maleate & | Each uncoated tablet contains: | ||
| Hydrochlorothiazide | Enalapril Maleate | IP | 10mg | |
| Tablets IP | Hydrochlorothiazide | IP | 25mg | |
| Excipients | q.s | |||
| 120 | Isoxsuprine | Each uncoated tablet contains: | ||
| Hydrochloride Tablets | Isoxsuprine Hydrochloride | IP | 10mg | |
| IP | Excipients | q.s | ||
| 121 | Betahistine | Each film coated tablet contains: | ||
| Hydrochloride | Betahistine Hydrochloride | IP | 8mg | |
| Tablets IP(8 mg) | Excipients | q.s | ||
| Approved colour shall be used | ||||
| 122 | Betahistine | Each film coated tablet contains: | ||
| Hydrochloride | Betahistine Hydrochloride | IP | 16mg | |
| Tablets IP (16 mg) | Excipients | q.s | ||
| Approved colour shall be used | ||||
| 123 | Cetirizine | Each film coated tablet contains: | ||
| Hydrochloride | Cetirizine Hydrochloride | IP | 10mg | |
| Tablets IP (10 mg) | Excipients | q.s | ||
| Approved colour shall be used | ||||
| 124 | Baclofen Tablets IP | Each uncoated tablet contains: | ||
| (10mg) | Baclofen | IP | 10 mg | |
| Excipients | q.s | |||
| 125 | Drotaverine HCl Tablets IP | Each film coated tablet contains: | ||
| IP (80 mg) | Drotaverine Hydrochloride | IP | 80mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 126 | Calcium Pantothenate | Each film coated tablet contains: | ||
| Tablets IP (300 mg) | Calcium Pantothenate | IP | 300mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 127 | Cefixime Tablets IP | Each film coated tablet contains: | ||
| ( 200mg) | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 200 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 128 | Cholecalciferol Tablets | Each film coated tablet contains: | ||
| IP (1000 I.U.) | Cholecalciferol | IP | 1000 I.U | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 129 | Clomiphene Citrate | Each uncoated tablet contains: | ||
| Tablets IP (50 mg) | Clomiphene citrate | IP | 50mg | |
| Excipients | qs | |||
| 130 | Serratiopeptidase Tablets IP | Each film coated tablet contains: | ||
| Serratiopeptidase | IP | 20mg | ||
| As enteric coated granules | ||||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 131 | Atorvastatin Tablets IP | Each film coated tablet contains: | ||
| Atorvastatin Calcium | IP | |||
| eq. to Atorvastatin | 80mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 132 | Cefuroxime Axetil Tablets IP | Each film coated tablet contains: | ||
| (250 mg) | Cefuroxime Axetil | IP | ||
| eq. to Cefuroxime | 250 mg | |||
| Excipients | qs | |||
| 133 | Cefuroxime Axetil Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Cefuroxime Axetil | IP | ||
| eq. to Cefuroxime | 500 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 134 | Dothiepin Hydrochloride | Each film coated tablet contains: | ||
| Tablets IP (25 mg) | Dothiepin Hydrochloride | IP | 25mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 135 | Calcium Pantothenate | Each film coated tablet contains: | ||
| Tablets IP (100 mg) | Calcium Pantothenate | IP | 100mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 136 | Clarithromycin Tablets IP | Each film coated tablet contains: | ||
| (250 mg) | Clarithromycin | IP | 250 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 137 | Clarithromycin Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Clarithromycin | IP | 500 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 138 | Amlodipine Tablets IP (5 mg) | Each uncoated tablet contains: | ||
| Amlodipine Besilate | IP | |||
| eq.to Amlodipine | 5 mg | |||
| Excipients | q.s | |||
| 139 | Amlodipine Tablets IP (10 mg) | Each uncoated tablet contains: | ||
| Amlodipine Besilate | IP | |||
| eq.to Amlodipine | 10 mg | |||
| Excipients | q.s | |||
| 140 | Esomeprazole Tablets IP | Each enteric coated tablet contains: | ||
| Esomeprazole Magnesium | IP | |||
| eq.to Esomeprazole | 20 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 141 | Esomeprazole Tablets IP | Each enteric coated tablet contains: | ||
| Esomeprazole Magnesium | IP | |||
| eq.to Esomeprazole | 40 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 142 | Amoxycillin & Potassium | Each film coated tablet contains: | ||
| Clavulanate Tablets IP | Amoxycillin Trihydrate | IP | ||
| eq.to Amoxycillin | 250 mg | |||
| Potassium Clavulanate diluted | IP | |||
| eq.to Clavulanac Acid | 125 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 143 | Amoxycillin & Potassium | Each film coated tablet contains: | ||
| Clavulanate Tablets IP | Amoxycillin Trihydrate | IP | ||
| eq.to Amoxycillin | 875 mg | |||
| Potassium Clavulanate diluted | IP | |||
| eq.to Clavulanac Acid | 125 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 144 | Amoxycillin & Potassium | Each film coated tablet contains: | ||
| Clavulanate Tablets IP | Amoxycillin Trihydrate | IP | ||
| eq.to Amoxycillin | 500 mg | |||
| Potassium Clavulanate diluted | IP | |||
| eq.to Clavulanac Acid | 125 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 145 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||
| Levofloxacin Hemihydrate | IP | |||
| eq.to Levofloxacin | 750 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 146 | Cefixime & | Each film coated tablet contains: | ||
| Ofloxacin Tablets IP | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 100 mg | |||
| Ofloxacin | IP | 100 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 147 | Linezolid Tablets IP | Each film coated tablet contains: | ||
| (600 mg ) | Linezolid | IP | 600 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 148 | Ursodeoxycholic Acid | Each uncoated tablet contains: | ||
| Tablets IP (150 mg) | Ursodeoxycholic Acid | IP | 150 mg | |
| Excipients | q.s | |||
| 149 | Ursodeoxycholic Acid | Each uncoated tablet contains: | ||
| Tablets IP (300 mg) | Ursodeoxycholic Acid | IP | 300 mg | |
| Excipients | q.s | |||
| 150 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||
| (60 mg) | Etoricoxib | IP | 60 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 151 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||
| (90 mg) | Etoricoxib | IP | 90 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 152 | Rosuvastatin Tablets IP | Each film coated tablet contains: | ||
| ( 5 mg) | Rosuvastatin Calcium | IP | ||
| eq.to Rosuvastatin | 5 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 153 | Cefixime | Each uncoated tablet contains: | ||
| Tablets IP (400 mg) | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 400 mg | |||
| Excipients | q.s | |||
| 154 | Terbinafine Hydrochloride | Each uncoated tablet contains: | ||
| Tablets IP (500 mg) | Terbinafine Hydrochloride | IP | ||
| eq.to Terbinafine | 500 mg | |||
| Excipients | q.s | |||
| 155 | Tranexamic Acid Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Tranexamic Acid | IP | 500 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 156 | Fexofenadine HCl Tablets IP | Each film coated tablet contains: | ||
| (120 mg) | Fexofenadine Hydrochloride | IP | 120 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 157 | Baclofen Tablets IP(25 mg) | Each uncoated tablet contains: | ||
| Baclofen | IP | 25 mg | ||
| Excipients | q.s | |||
| 158 | Sildenafil Tablets IP | Each film coated tablet contains: | ||
| (50mg) | Sildenafil Citrate | IP | ||
| Eq to Sildenafil | 50 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 159 | Sildenafil Tablets IP | Each film coated tablet contains: | ||
| (100mg) | Sildenafil Citrate | IP | ||
| Eq to Sildenafil | 100 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 160 | Tadalafil Tablets IP | Each film coated tablet contains: | ||
| (10mg) | Tadalfil | IP | 10 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 161 | Tadalfil Tablets IP | Each film coated tablet contains: | ||
| (20mg) | Tadalfil | IP | 20 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 162 | Rosuvastatin Tablets IP | Each film coated tablet contains: | ||
| (10 mg) | Rosuvastatin Calcium | IP | ||
| eq.to Rosuvastatin | 10 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 163 | Rosuvastatin Tablets IP | Each film coated tablet contains: | ||
| (20 mg) | Rosuvastatin Calcium | IP | ||
| eq.to Rosuvastatin | 20 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 164 | Cholecalciferol Tablets IP | Each film coated tablet contains: | ||
| (60000 I.U.) | Cholecalciferol | IP | 60000 I.U | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 165 | Voriconazole Tablets IP | Each film coated tablet contains: | ||
| (200 mg) | Voriconazole | IP | 200 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 166 | Rosuvastatin Tablets IP | Each film coated tablet contains: | ||
| (40 mg) | Rosuvastatin Calcium | IP | ||
| eq.to Rosuvastatin | 40 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 167 | Nitrofurantoin Tablets IP | Each uncoated tablet contains: | ||
| (100 mg) | Nitrofurantoin | IP | 100 mg | |
| Excipients | q.s | |||
| 168 | Sitagliptin Tablets IP (50 mg) | Each film coated tablet contains: | ||
| Sitagliptin Phosphate Monohydrate | IP | |||
| eq.to Sitagliptin | 50 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 169 | Sitagliptin Tablets IP (100 mg) | Each film coated tablet contains: | ||
| Sitagliptin Phosphate Monohydrate | IP | |||
| eq.to Sitagliptin | 100 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 170 | Atorvastatin & Fenofibrate | Each film coated tablet contains: | ||
| Tablets IP | Atorvastatin Calcium | IP | ||
| eq.to Atrovastatin | 10 mg | |||
| Fenofibrate | IP | 160mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 171 | Flavoxate Tablets IP | Each film coated tablet contains: | ||
| Flavoxate Hydrochloride | 200 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 172 | Dapoxetine Tablets IP | Each film coated tablet contains: | ||
| Dapoxetine Hydrochloride | IP | |||
| eq.to Dapoxetine | 30 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 173 | Cefixime & Potassium | Each film coated tablet contains: | ||
| Clavulanate Tablets | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 200 mg | |||
| Potassium Clavulanate diluted | IP | |||
| eq.to Clavulanac Acid | 125 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 174 | Moxifloxacin Tablets | Each film coated tablet contains: | ||
| Moxifloxacin hydrochloride | IP | |||
| eq.to Moxifloxacin | 400 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 175 | Aceclofenac & Drotaverine | Each film coated tablet contains: | ||
| Hydrochloride Tablets | Aceclofenac | IP | 100 mg | |
| Drotaverine Hydrochloride | IP | 80 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 176 | Aceclofenac Sustained | Each uncoated sustained release tablet contains: | ||
| Release tablets | Aceclofenac | IP | 200 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 177 | Lornoxicam Tablets | Each film coated tablet contains: | ||
| Lornoxicam | 4 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 178 | Lornoxicam Tablets | Each film coated tablet contains: | ||
| Lornoxicam | 8 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 179 | Lornoxicam & | Each film coated tablet contains: | ||
| Thiocolchicoside Tablets | Lornoxicam | 4 mg | ||
| Thiocolchicoside | IP | 8 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 180 | Tranexamic Acid & | Each film coated tablet contains: | ||
| Mefenamic Acid Tablets | Tranexamic Acid | IP | 500 mg | |
| Mefenamic Acid | IP | 250 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 181 | Vildagliptin & Metformin | Each film coated tablet contains: | ||
| Hcl Tablets | Vildagliptin | 50 mg | ||
| Metformin Hydrochloiride | IP | 1000 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 182 | Rabeprazole Tablets IP | Each enteric coated tablet contains: | ||
| (20 mg) | Rabeprazole Sodium | IP | 20 mg | |
| Approved colour shall be used | ||||
| 183 | Rabeprazole & | Each enteric coated tablet contains: | ||
| Domperidone Tablets | Rabeprazole Sodium | IP | 20 mg | |
| Domperidone | IP | 10 mg | ||
| Approved colour shall be used | ||||
| 184 | Pantoprazole Tablets IP | Each enteric coated tablet contains: | ||
| (40 mg) | Pantoprazole Sodium | IP | ||
| equivalent to Pantoprazole | 40 mg | |||
| Approved colour shall be used | ||||
| 185 | Pantoprazole & | Each enteric coated tablet contains: | ||
| Domperidone Tablets | Pantoprazole Sodium | IP | ||
| equivalent to Pantoprazole | 40 mg | |||
| Domperidone | IP | 10 mg | ||
| Approved colour shall be used | ||||
| 186 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||
| (200 mg) | Ofloxacin | IP | 200 mg | |
| Approved colour shall be used | ||||
| 187 | Ofloxacin & | Each film coated tablet contains: | ||
| Ornidazole Tablets | Ofloxacin | IP | 200 mg | |
| Ornidazole | IP | 500 mg | ||
| Approved colour shall be used | ||||
| 188 | Levocetirizine Tablets IP | Each film coated tablet contains: | ||
| (5 mg) | Levocetirizine Hydrochloride | IP | 5 mg | |
| 189 | Aceclofenac & Paracetamol | Each film coated tablet contains: | ||
| Tablets | Aceclofenac | IP | 100 mg | |
| Paracetamol | IP | 325 mg | ||
| Approved colour shall be used | ||||
| 190 | Aceclofenac & Paracetamol | Each uncoated tablet contains: | ||
| Tablets | Aceclofenac | IP | 100 mg | |
| Paracetamol | IP | 325 mg | ||
| 191 | Montelukast Sodium & | Each film coated tablet contains: | ||
| Levocetirizine Hydrochloride | Montelukast Sodium | IP | ||
| Tablets IP | eq.to Montelukast | 10 mg | ||
| Levocetirizine Hydrochloride | IP | 5 mg | ||
| Approved colour shall be used | ||||
| 192 | Azithromycin Tablets IP | Each film coated tablet contains: | ||
| (250 mg) | Azithromycin Dihydrate | IP | ||
| eq.to Azithromycin | 250 mg | |||
| Approved colour shall be used | ||||
| 193 | Azithromycin Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Azithromycin Dihydrate | IP | ||
| eq.to Azithromycin | 500 mg | |||
| Approved colour shall be used | ||||
| 194 | Cefixime Dispersible | Each uncoated dispersible tablet contains: | ||
| Tablets IP (100 mg) | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 100 mg | |||
| 195 | Cefixime Dispersible | Each uncoated dispersible tablet contains: | ||
| Tablets IP (200 mg) | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 200 mg | |||
| 196 | Cefpodoxime Dispersible | Each uncoated dispersible tablet contains: | ||
| Tablets IP (100 mg) | Cefpodoxime Proxetil | IP | ||
| eq.to Cefpodoxime | 100 mg | |||
| 197 | Cefpodoxime Dispersible | Each uncoated dispersible tablet contains: | ||
| Tablets IP (200 mg) | Cefpodoxime Proxetil | IP | ||
| eq.to Cefpodoxime | 200 mg | |||
| 198 | Cefixime & Ofloxacin | Each film coated tablet contains: | ||
| Tablets | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 200 mg | |||
| Ofloxacin | IP | 200 mg | ||
| Approved colour shall be used | ||||
| 199 | Calcium & Vitamin D3 | Each film coated tablet contains: | ||
| Tablets IP | Calcium Carbonate | 1250 | ||
| (derived from organic source | ||||
| oyster shell) | IP | |||
| Eq.to Elemental Calcium | 500 mg | |||
| Vitamin D3 | IP | 250 IU | ||
| Approved colour shall be used | ||||
| 200 | Nimesulide ,Paracetamol , | Each uncoated bolus contains: | ||
| Serratiopeptidase , | Nimesulide | BP | 500 mg | |
| Vitamin E & Selenium Bolus | Paracetamol | IP | 2.0 gm | |
| (For Veterinary use only) | Serratiopeptidase | IP | 50 mg | |
| (as enteric coated granules) | ||||
| Vitamin E | 500 IU | |||
| Selenium | 5 mg | |||
| 201 | Calcium Citrate , Vitamin D3 | Each film coated tablet contains: | ||
| Zinc Sulphate,Magnesium | Calcium Citrate | USP | 1000 mg | |
| Hydroxide Tablets | Vitamin D3 | IP | 250 IU | |
| Zinc Sulphate Monohydrate | IP | 66 mg | ||
| Magnesium Hydroxide | IP | 40 mg | ||
| Approved colour shall be used | ||||
| 202 | Etoricoxib & Thiocolchicoside | Each film coated tablet contains: | ||
| Tablets | Etoricoxib | IP | 60 mg | |
| Thiocolchicoside | IP | 4 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 203 | Cefpodoxime & Ofloxacin | Each film coated tablet contains: | ||
| Tablets | Cefpodoxime Proxetil | IP | ||
| eq.to Cefpodoxime | 200 mg | |||
| Ofloxacin | IP | 200 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 204 | Cefpodoxime & Potassium | Each film coated tablet contains: | ||
| Clavulanate Tablets | Cefpodoxime proxetil | IP | ||
| eq.to Cefpodoxime | 200 mg | |||
| Potassium Clavulanate diluted | IP | |||
| eq.to Clavulanac Acid | 125 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 205 | Acebrophylline Sustained | Each uncoated sustained release tablet contains: | ||
| Release tablets | Acebrophylline | 200 mg | ||
| Excipients | q.s | |||
| 206 | Artemether & | Each uncoated tablet contains: | ||
| Lumefantrine Tablets | Artemether | IP | 80 mg | |
| Lumefantrine | 480 mg | |||
| Excipients | q.s | |||
| 207 | Doxofylline (S.R) With | Each uncoated tablet contains: | ||
| Montelukast Sodium | Doxofylline | IP | ||
| Tablets | (As Sustained release form) | 400 mg | ||
| Montelukast Sodium | IP | |||
| eq.to Montelukast | 10 mg | |||
| Excipients | q.s | |||
| 208 | Betahistine Hydrochloride | Each film coated sustained release tablet contains: | ||
| sustained release | Betahistine Hydrochloride | IP | 48mg | |
| Tablets | Excipients | q.s | ||
| Approved colour shall be used | ||||
| 209 | Feropenem Tablets | Each film coated tablet contains: | ||
| Feropenem Sodium | ||||
| eq.to Feropenem | 200 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 210 | Sitagliptin & Metformin | Each film coated tablet contains: | ||
| HydrochlorideTablets | Sitagliptin Phosphate Monohydrate | IP | ||
| eq.to Sitagliptin | 50 mg | |||
| Metformin Hydrochloride | IP | 1000 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 211 | Vildagliptin Tablets | Each uncoated tablet contains: | ||
| Vildagliptin | 50 mg | |||
| Excipients | qs | |||
| 212 | Vildagliptin Tablets | Each uncoated tablet contains: | ||
| Vildagliptin | 100 mg | |||
| Excipients | qs | |||
| 213 | Multivitamin Tablets | Each film coated tablet contains: | ||
| Alpha Lipoic acid | USP | 100 mg | ||
| Methylcobalamin | IP | 1500 mcg | ||
| Pyridoxine Hydrochloride | IP | 3 mg | ||
| Folic Acid | IP | 1.5 mg | ||
| Vitamin D3 | IP | 1000 I.U. | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 214 | Febuxostat Tablets | Each film coated tablet contains: | ||
| Febuxostat | 40 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 215 | Febuxostat Tablets | Each film coated tablet contains: | ||
| Febuxostat | 80 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 216 | Lornoxicam & | Each film coated tablet contains: | ||
| Thiocolchicoside Tablets | Lornoxicam | 8 mg | ||
| Thiocolchicoside | IP | 8 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 217 | Lornoxicam & | Each film coated tablet contains: | ||
| Thiocolchicoside Tablets | Lornoxicam | 4 mg | ||
| Thiocolchicoside | IP | 4 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 218 | Lornoxicam & | Each film coated tablet contains: | ||
| Thiocolchicoside Tablets | Lornoxicam | 8 mg | ||
| Thiocolchicoside | IP | 4 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 219 | Telmisartan & | Each uncoated tablet contains: | ||
| Hydrochlorothiazide Tablets | Telmisartan | IP | 80 mg | |
| IP | Hydrochlorothiazide | IP | 12.5 mg | |
| Excipients | q.s | |||
| 220 | Ramipril & | Each uncoated tablet contains: | ||
| Hydrochlorothiazide | Ramipril | IP | 2.5 mg | |
| Tablets IP | Hydrochlorothiazide | IP | 12.5 mg | |
| Excipients | qs | |||
| 221 | Metformin HCl Tablets | Each uncoated tablet contains: | ||
| IP | Metformin Hydrochloride | IP | 500 mg | |
| Excipients | q.s | |||
| 222 | Diclofenac Sodium Tablets | Each enteric coated tablet contains: | ||
| IP (50 mg) | Diclofenac Sodium | IP | 50 mg | |
| Excipients | q.s | |||
| 223 | Cefixime Tablets IP | Each film coated tablet contains: | ||
| (100 mg) | Cefixime | IP | ||
| eq.to Cefixime (Anhydrous) | 100 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 224 | Cyproheptadine Tablet IP | Each uncoated tablet contains: | ||
| (4 mg) | Cyproheptadine Hydrochloride | IP | 4 mg | |
| Excipients | q.s | |||
| 225 | Satranidazole & Ofloxacin | Each film coated tablet contains: | ||
| Tablets | Satranidazole | USP | 300 mg | |
| Ofloxacin | IP | 200 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 226 | Albendazole & Ivermectin | Each uncoated tablet contains: | ||
| Tablets | Albendazole | IP | 400 mg | |
| Ivermectin | IP | 6 mg | ||
| Excipients | q.s | |||
| 227 | Fluconazole Tablet IP | Each uncoated tablet contains: | ||
| (300mg) | Fluconazole | IP | 300 mg | |
| Excipients | q.s | |||
| 228 | Vildagliptin & Metformin | Each film coated tablet contains: | ||
| HCl Tablets | Vildagliptin | 50 mg | ||
| Metformin Hydrochloiride | IP | 500 mg | ||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 229 | Memantine HCl & | Each film coated tablet contains: | ||
| Donepezil HCl Tablets | Memantine Hydrochloride | IP | 5 mg | |
| Donepezil Hydrochloride | IP | 5 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 230 | Memantine HCl & | Each film coated tablet contains: | ||
| Donepezil HCl Tablets | Memantine Hydrochloride | IP | 10 mg | |
| Donepezil Hydrochloride | IP | 5 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 231 | Tapentadol Extended | Each uncoated Extended release tablet contains: | ||
| release Tablets | Tapentadol Hydrochloride | IP | ||
| eq.to Tapentadol | 50 mg | |||
| Excipients | q.s | |||
| 232 | Pitavastatin Calcium | Each film coated tablet contains: | ||
| Tablets (4mg) | Pitavastatin Calcium | IP | ||
| eq.to Pitavastatin | 4 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 233 | Tapentadol Hydrochloride | Each film coated tablet contains: | ||
| Tablets | Tapentadol Hydrochloride | IP | ||
| eq.to Tapentadol | 100 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 234 | Escitalopram Tablets IP | Each film coated tablet contains: | ||
| (5 mg) | Escitalopram Oxalate | IP | ||
| eq.to Escitalopram | 5 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 235 | Escitalopram Tablets IP | Each film coated tablet contains: | ||
| (10 mg) | Escitalopram Oxalate | IP | ||
| eq.to Escitalopram | 10 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 236 | Olanzapine Tablets IP | Each film coated tablet contains: | ||
| (2.5 mg) | Olanzapine | IP | 2.5 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 237 | Olanzapine Tablets IP | Each film coated tablet contains: | ||
| (10 mg) | Olanzapine | IP | 10 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 238 | Voglibose Tablets IP | Each uncoated tablet contains: | ||
| (0.2 mg ) | Voglibose | IP | 0.2 mg | |
| Excipients | q.s | |||
| 239 | Voglibose Tablets IP | Each uncoated tablet contains: | ||
| (0.3 mg ) | Voglibose | IP | 0.3 mg | |
| Excipients | q.s | |||
| 240 | Olanzapine Tablets IP | Each film coated tablet contains: | ||
| (5 mg ) | Olanzapine | IP | 5 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 241 | Clopidogrel Tablets IP | Each film coated tablet contains: | ||
| (75 mg) | Clopidogrel Bisulphate | IP | ||
| eq.to Clopidogrel | 75 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 242 | Citicoline Tablets IP | Each film coated tablet contains: | ||
| (500 mg) | Citicoline Sodium | IP | ||
| eq.to Citicoline | 500 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 243 | Piroxicam Tablets IP | Each uncoated tablet contains: | ||
| (20 mg) | Piroxicam | IP | 20 mg | |
| Excipients | q.s | |||
| 244 | Ebastine Tablets IP | Each film coated tablet contains: | ||
| (10 mg) | Ebastine | IP | 10 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 245 | Ebastine Tablets IP | Each film coated tablet contains: | ||
| (20 mg) | Ebastine | IP | 20 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 246 | Metformin HCl | Each uncoated sustained release tablet contains: | ||
| Sustained Release | Metformin Hydrochloride | IP | 750 mg | |
| Tablets IP | Excipients | q.s | ||
| 247 | Betahistine Dihydrochloride | Each uncoated sustained release tablet contains: | ||
| Sustained Release | Betahistine Dihydrochloride | IP | 24 mg | |
| Tablets | Excipients | q.s | ||
| 248 | Mecobalamine E.R. | Each Extended Release tablet contains: | ||
| Tablets | Mecobalamine | IP | 1500 mcg | |
| 249 | Montelukast Sodium & | Each film coated tablet contains: | ||
| Desloratadine Tablets | Montelukast Sodium | IP | ||
| eq.to Montelukast | 10 mg | |||
| Desloratadine | 5 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 250 | Olopatadine HCl Tablets | Each film coated tablet contains: | ||
| Olopatadine Hydrochloride | USP | 5 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 251 | Etoricoxib & | Each film coated tablet contains:- | ||
| Thiocolchicoside Tablets | Etoricoxib | IP | 60 mg | |
| Thiocolchicoside | IP | 8 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 252 | Linagliptin Tablets | Each film coated tablet contains:- | ||
| Linagliptin | 5 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 253 | Nebivolol & Amlodipine | Each uncoated tablet contains:- | ||
| Tablets | Nebivolol Hydrochloride | IP | ||
| eq.to Nebivolol | 5 mg | |||
| Amlodipine Besilate | IP | |||
| eq.to Amlodipine | 5 mg | |||
| Excipients | q.s | |||
| 254 | Nebivolol & | Each uncoated tablet contains:- | ||
| Hydrochlorothiazide | Nebivolol Hydrochloride | IP | ||
| Tablets | eq.to Nebivolol | 5 mg | ||
| Hydrochlorothiazide | IP | 12.5 mg | ||
| Excipients | q.s | |||
| 255 | Troxipide Tablets | Each film coated tablet contains:- | ||
| (100 mg) | Troxipide | IP | 100 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 256 | Rifaximin Tablets IP | Each film coated tablet contains:- | ||
| Rifaximin | IP | 200 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 257 | Rifaximin Tablets IP | Each film coated tablet contains:- | ||
| Rifaximin | IP | 400 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 258 | Escitalopram Tablets IP | Each film coated tablet contains:- | ||
| (20 mg) | Escitalopram Oxalate | IP | ||
| eq.to Escitalopram | 20 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 259 | Chlorthalidone Tablets IP | Each film coated tablet contains:- | ||
| (50 mg) | Chlorthalidone | IP | 50 mg | |
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 260 | Naproxen Tablets IP | Each uncoated tablet contains:- | ||
| (250 mg) | Naproxen | IP | 250 mg | |
| Excipients | q.s | |||
| 261 | Naproxen Tablets IP | Each uncoated tablet contains:- | ||
| (500 mg) | Naproxen | IP | 500 mg | |
| Excipients | q.s | |||
| 262 | Iron & Folic Acid | Each film coated tablet contains:- | ||
| Tablets IP | Ferrous Sulphate | IP | ||
| eq.to elemental Ferrous Iron | 100 mg | |||
| Folic Acid | IP | 0.5 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 263 | Nimesulide, | Each uncoated tablet contains:- | ||
| Phenylephrine HCl & | Nimesulide | BP | 100 mg | |
| Levocetirizine | Phenylephrine Hydrochloride | IP | 5 mg | |
| Dihydrochloride Tablets | Levocetirizine Dihydrochloride | IP | 5 mg | |
| Excipients | q.s | |||
| 264 | Trypsin , Bromelain , | Each enteric coated tablet contains: | ||
| Rutoside & Diclofenac | Trypsin | BP | 48 mg | |
| Sodium Tablets | Bromelain | 90 mg | ||
| Rutoside trihydrate | BP | 100 mg | ||
| Diclofenac Sodium | IP | 50 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 265 | Glucosamine Sulphate | Each film coated tablet contains: | ||
| Potassium Chloride , | Glucosamine Sulphate | |||
| Methyl Sulphonyl Methane | Potassium Chloride | USP | 750 mg | |
| & Diacerein Tablets | eq.to Glucosamine | 446 mg | ||
| Diacerein | IP | 50 mg | ||
| Methyl Sulphonyl Methane | USP | 250 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 266 | Pregabalin , Nortriptyline | Each film coated tablet contans:- | ||
| Methylcobalamin Tablets | Pregabalin | IP | 75 mg | |
| Nortriptyline Hydrochloride | IP | |||
| eq.to Nortriptyline | 10 mg | |||
| Methylcobalamin | IP | 1500 mcg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 267 | Voglibose , Glimepiride & | Each uncoated bilyed tablet conatins:- | ||
| Metformin HCl (S.R) | Voglibose | IP | 0.2 mg | |
| Tablets | Glimepiride | IP | 2 mg | |
| Metformin Hydrochloride | IP | 500 mg | ||
| (In a Sustained release form) | ||||
| Excipients | q.s | |||
| 268 | Pregabalin , Nortriptyline | Each film coated tablet contains:- | ||
| Tablets | Pregabalin | IP | 75 mg | |
| Nortriptyline Hydrochloride | IP | |||
| eq.to Nortriptyline | 10 mg | |||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 269 | Calcium Citrate Malate, | Each film coated tablet contains: | ||
| Vitamin D3, | Calcium Citrate Malate | 1250 mg | ||
| Methylcobalamin, | Vitamin D3 | IP | 1000 I.U | |
| Vitamin K2-7 & Zinc Tablets | Methylcobalamin | IP | 1500 mcg | |
| Vitamin K2-7 | 90 mcg | |||
| Zinc Oxide | IP | 15 mg | ||
| Magnesium Oxide | IP | 50 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 270 | Voglibose , Glimepiride & | Each uncoated bilayered tablet conatins:- | ||
| Metformin Hydrochloride | Voglibose | IP | 0.2 mg | |
| (S.R) Tablets | Glimepiride | IP | 1 mg | |
| Metformin Hydrochloride | IP | 500 mg | ||
| (In a Sustained release form) | ||||
| Excipients | q.s | |||
| 271 | Metformin Hydrochloride | Each uncoated bilayered tablet contains: | ||
| (S.R) & Glimepiride | Glimepiride | IP | 3 mg | |
| Tablets | Metformin Hydrochloride | IP | 500 mg | |
| ( In sustained- release form) | ||||
| Excipients | qs | |||
| 272 | Paracetamol,Phenylephrine | Each film coated tablet contains:- | ||
| HCl,Caffeine & | Paracetamol | IP | 500 mg | |
| Diphenhydramine HCl | Phenylephrine Hydrochloride | IP | 5 mg | |
| Tablets | Caffeine (Anhydrous) | IP | 30 mg | |
| Diphenhydramine Hydrochloride | IP | 25 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 273 | Paracetamol (IR) 300 mg & | Each uncoated bilayered tablet contains:- | ||
| Paracetamol (S.R) 700 mg | Paracetamol | IP | 300 mg | |
| Tablets | (As Immediate Release) | |||
| Paracetamol | IP | 700 mg | ||
| (As Sustained Release) | ||||
| Excipients | q.s | |||
| 274 | Aceclofenac ,Paracetamol & | Each film coated tablet contains: | ||
| Thiocolchicoside Tablets | Aceclofenac | IP | 100 mg | |
| Paracetamol | IP | 325 mg | ||
| Thiocolchicoside | IP | 4 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 275 | Trypsin , Bromelain & | Each enteric coated tablet contains: | ||
| Rutoside Trihydrate Tablets | Trypsin | BP | 48 mg | |
| Bromelain | 90 mg | |||
| Rutoside Trihydrate | BP | 100 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 276 | Trypsin , Bromelain & | Each enteric coated tablet contains: | ||
| Rutoside Trihydrate Tablets | Trypsin | BP | 96 mg | |
| Bromelain | 180 mg | |||
| Rutoside Trihydrate | BP | 200 mg | ||
| Excipients | q.s | |||
| Approved colour shall be used | ||||
| 277 | Cetirizine HCl , | Each uncoated tablet contains:- | ||
| Phenylephrine HCl & | Cetirizine Hydrochloride | IP | 5 mg | |
| Ambroxol Hydrochloride | Phenylephrine Hydrochloride | IP | 5 mg | |
| Tablets | Ambroxol Hydrochloride | IP | 15 mg | |
| Excipients | q.s | |||
| 278 | Salbutamol Sulphate, | Each uncoated tablet contains:- | ||
| Bromhexine Hydrochloride | Salbutamol Sulphate | IP | ||
| & Phenylephrine | eq.to salbutamol | 4 mg | ||
| Hydrochloride Tablets | Bromhexine Hydrochloride | IP | 8 mg | |
| Phenylephrine Hydrochloride | IP | 10 mg | ||
| Excipients | q.s | |||
| 279 | Pioglitazone HCl , | Each uncoated bilayer tablet contains:- | ||
| Metformin HCl Sustained | Pioglitazone Hydrochloride | IP | ||
| Release & Glimepiride | eq.to Pioglitazone | 15 mg | ||
| Tablets | Metformin Hydrochloride | IP | 500 mg | |
| (As Sustained Release) | ||||
| Glimepiride | IP | 1 mg | ||
| Excipients | q.s | |||
| 280 | Pioglitazone HCl , | Each uncoated bilayer tablet contains:- | ||
| Metformin HCl Sustained | Pioglitazone Hydrochloride | IP | ||
| Release & Glimepiride | eq.to Pioglitazone | 15 mg | ||
| Tablets | Metformin Hydrochloride | IP | 500 mg | |
| (As Sustained Release) | ||||
| Glimepiride | IP | 2 mg | ||
| Excipients | q.s | |||
| 281 | Teneligliptin & Metformin Hydrochloride (ER) Tablets | Each uncoated Bilayer tablet contain: | ||
| Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin | 20 mg | |||
| Metformin Hydrochloride | IP | |||
| (Extend Release) | 500mg | |||
| Excipients | q.s | |||
| 282 | Teneligliptin & Metformin Hydrochloride (ER) Tablets | Each uncoated Bilayer tablet contain: | ||
| Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin | 20 mg | |||
| Metformin Hydrochloride | IP | 1000mg | ||
| (Extend Release) | ||||
| Excipients | q.s | |||
| 283 | Rabeprazole Sodium & Ondansetron Tablets | Each enteric coated tablet contains: | ||
| Rabeprazole Sodium | IP | 20 mg | ||
| Ondansetron Hydrochloride | IP | |||
| Eq. to Ondansetron | 4 mg | |||
| Excipients | q.s. | |||
| Approved colour shall be used | ||||
| 284 | Voglibose and Metformin Hydrochloride Prolonged release Tablets | Each uncoated tablet contain: | ||
| Voglibose | IP | 0.3 mg | ||
| Metformin Hydrochloride | IP | 1000 mg | ||
| (Prolonged release) | ||||
| 285 | Voglibose and Metformin Hydrochloride Prolonged release Tablets | Each uncoated tablet contain: | ||
| Voglibose | IP | 0.2 mg | ||
| Metformin Hydrochloride | IP | 1000 mg | ||
| (Prolonged release) | ||||
| 286 | Telmisartan, Amlodipine and Hydrochlorothiazide Tablets | Each uncoated bilayer tablet contain: | ||
| Telmisartan | IP | 20mg | ||
| Amlodipine Besilate | IP | |||
| Eq. to Amlodipine | 2.5 mg | |||
| Hydrochlorothiazide | IP | 12.5 mg | ||
| 287 | Telmisartan and Metoprolol Succinate(ER) Tablets | Each filmcoated tablet contain: | ||
| Telmisartan | IP | 40 mg | ||
| Metoprolol Succinate | IP | |||
| Eq. to Metoprolol Tartrate | 25 mg | |||
| (As Extended release) | ||||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 288 | Telmisartan, Amlodipine and Hydrochlorothiazide Tablets | Each uncoated bilayer tablet contain: | ||
| Telmisartan | IP | 40 mg | ||
| Amlodipine Besilate | IP | |||
| Eq. to Amlodipine | 5 mg | |||
| Hydrochlorothiazide | IP | 12.5 mg | ||
| 289 | Atorvastatin and | Each film coated tablet contain: | ||
| Fenofibrate Tablets | Atorvastatin Calcium | IP | ||
| Eq. to Atorvastatin | 10 mg | |||
| Fenofibrate | IP | 160 mg | ||
| 300 | Atorvastatin and | Each film coated tablet contain: | ||
| Amlodipine Tablets | Atorvastatin Calcium | IP | ||
| Eq. to Atorvastatin | 10 mg | |||
| Amlodepine Besilate | IP | |||
| Eq. to Amlodepine | 5 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 301 | Olmesartan Medoxomil and Amlodipine Tablets | Each film coated tablet contain: | ||
| Olmesartan Medoxomil | IP | 20 mg | ||
| Amlodepine Besilate | IP | |||
| Eq. to Amlodepine | 5 mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 302 | Atorvastatin and | Each film coated tablet contain: | ||
| Ezetimibe Tablets | Atorvastatin Calcium | IP | ||
| Eq. to Atorvastatin | 10 mg | |||
| Ezetimibe | IP | 10 mg | ||
| 303 | Telmisartan and S (-) Amlodipine Tablets | Each film coated tablet contain: | ||
| Telmisartan | IP | 40 mg | ||
| S (-) Amlodepine Besilate | IP | |||
| Eq. to S (-) Amlodepine | 5 mg | |||
| 304 | Piracetam & | Each film coated tablet contain: | ||
| Citicoline Tablets | Piracetam | IP | 800mg | |
| Citicoline Sodium | IP | |||
| eq. to Citicoline | 500mg | |||
| Excipients | qs | |||
| Approved colour shall be used | ||||
| 305 | Ibuprofen ,Paracetamol & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains: | ||
| Ibuprofen | IP | 400mg | ||
| Paracetamol | IP | 325mg | ||
| Chlorpheniramine Maleate | IP | 2mg | ||
| Excipients | q.s. | |||
| 306 | Cetirizine HCl & Ambroxol HCl Tablets | Each film coated tablet contains: | ||
| Cetirizine HCl | IP | 5mg | ||
| Ambroxol HCl | IP | 60mg | ||
| Excipients | q.s. | |||
| 307 | Ranitidine, Magaldrate & Simethicone Tablets | Each film coated tablet contains: | ||
| Ranitidine HCl | IP | |||
| eq. to Ranitidine | 150mg | |||
| Magaldrate | IP | 200mg | ||
| Simethicone | IP | 20mg | ||
| Excipients | q.s | |||
| 308 | Omeprazole & Domperidone Tablets | Each enteric coated tablet contain: | ||
| Omeprazole Magnesium | IP | |||
| eq. to Omeprazole | 20mg | |||
| Domperidone | IP | 10mg | ||
| Excipients | q.s | |||
| 309 | Olmesartan Medoxomil , Amlodipine & Hydrochlorothiazide Tablets | Each film coated tablet contains: | ||
| Olmesartan Medoxomil | IP | 20mg | ||
| Amlodipine Besylate | IP | |||
| eq. to Amlodipine | 5mg | |||
| Hydrochlorothiazide | IP | 12.5mg | ||
| Excipients | q.s. | |||
| 310 | Telmisartan & Rosuvastatin Tablets | Each film coated tablet contains: | ||
| Telmisartan | IP | 40mg | ||
| Rosuvastatin Calcium | IP | |||
| Eq. to Rosuvastatin | 10mg | |||
| Excipients | q.s | |||
| 311 | Calcium Orotate & Vitamin D3 Tablets | Each film coated tablet contains: | ||
| Calcium Orotate | 740mg | |||
| Vitamin D3 | IP | 1000IU | ||
| Excipients | ||||
| Each film coated tablet contain: | ||||
| Drotaverine Hydrochloride Excipients | ||||
| 80mg | ||||
| IP | q.s | |||
| Each uncoated tablet contain: | ||||
| Fluconazole | 200mg | |||
| Excipients | IP | q.s | ||
| Approved colour shall be used | ||||
| Each uncoated tablet contain: | ||||
| Aciclovir | ||||
| Excipients | IP | 800mg | ||
| q.s | ||||
| Each film coated tablet contains: | ||||
| Cefuroxime Axetil | ||||
| eq. to anhydrous Cefuroxime | IP | |||
| Potassium Clavulate dilued | 250mg | |||
| eq. to Clavulanic Acid | IP | |||
| Excipients | 125mg | |||
| q.s | ||||
|
316 |
Pregabalin (SR) & Methylcobalamin Tablets |
Each uncoated tablet contain: | ||
| Pregabalin | 150mg | |||
| (As a sustained release form ) | IP | |||
| Methylcobalamin | 1500mcg q.s | |||
| Excipients | IP | |||
| Each film coated tablet contains: | ||||
| Vitamin C | IP | |||
| Zinc Citrate | 500mcg | |||
| Selenium | BP | 2.2mg | ||
| Excipients | 60mcg q.s | |||
| Each film coated tablet contains: | ||||
| Tranexamic Acid | IP | 250mg | ||
| Ethamsylate | BP | 250mg | ||
| Excipients | q.s | |||
|
319 |
Pregabalin (SR) & Methylcobalamin Tablets |
Each uncoated tablet contain: | ||
| Pregabalin | IP | 75mg | ||
| (As a sustained release form ) | ||||
| Methylcobalamin | IP | 1500mcg q.s | ||
| Excipients | ||||
| Each film coated tablet contains: | ||||
| Ciprofloxacin HCl | IP | |||
| eq. to Ciprofloxacin | 500mg 500mg q.s | |||
| Ornidazole | IP | |||
| Excipients | ||||
| Each uncoated tablet contain: | ||||
| Amlodipine Besylate | IP | |||
| eq.to Amlodipine | ||||
| Atorvastatin calcium | IP | 5mg | ||
| eq. to Atorvastatin | ||||
| Excipients | 10mg | |||
| q.s | ||||
|
322 |
Ofloxacin & Tinidazole Tablets | Each film coated tablet contains: | ||
| Ofloxacin | IP | |||
| Tinidazole | IP | 200mg | ||
| Excipients | 600mg q.s | |||
| Ivermectin & Albendazole Tablets | Each uncoated tablet contains: | |||
| Ivermectin | IP | 12mg | ||
| Albendazole | IP | 400mg | ||
| Excipients | q.s. | |||
| Each uncoated tablet contain: | ||||
| Paracetamol | IP | 650mg | ||
| Caffeine (anhydrous) | IP | 50mg | ||
| Excipients | q.s | |||
| Each uncoated tablet contain: | ||||
| Metformin Hydrochloride Gliclazide | 500mg 80mg | |||
| Excipients | IP | q.s | ||
| IP | ||||
| 326 | Cefuroxime Axetil & Potassium Clavulate Tablets | Each film coated tablet contains: | ||
| Cefuroxime Axetil | IP | |||
| eq. to anhydrous Cefuroxime | ||||
| Potassium Clavulate dilued | IP | 500mg | ||
| eq. to Clavulanic Acid | ||||
| Excipients | 125mg | |||
| q.s | ||||
| 327 | Cefixime, Cloxacillin & Lactobacillus Tablets | Each film coated tablet contains: | ||
| Cefixime | IP | |||
| eq.to Cefixime (Anhydrous) Cloxacillin Sodium | ||||
| eq. to Cloxacillin | IP | 200mg | ||
| Lactobacillus | ||||
| Excipients | 500mg | |||
| 90Million spores | ||||
| q.s | ||||
| Each film coated tablet contains: | ||||
| Calcium Orotate | ||||
| Vitamin D3 | 740mg 500IU q.s | |||
| Excipients | IP | |||
|
329 |
Ferrous Ascorbate, Folic Acid , Cyanocobalamin & Zinc Sulphate Tablets |
Each film coated tablet: | ||
| Ferrous Ascorbate | ||||
| eq. to Elemental Iron | 100mg | |||
| Folic Acid | 1.5mg 15mcg | |||
| Cyanocobalamin | ||||
| Zinc Sulphate Monohydrate | IP | 22.5mg | ||
| eq. to Elemental Zinc | IP | q.s. | ||
| Excipients | IP | |||
| Each uncoated tablet contain: | ||||
| Phenylephrine Hydrochloride Chlorpheniramine Maleate | IP | 10mg | ||
| Excipients | IP | 4mg | ||
| q.s. | ||||
| Each filmcoated tablet contain: | ||||
| Methylcobalamin | IP | 300 mg | ||
| Gabapentin | IP | 500mcg | ||
| Alpha Lipoc Acid | USP | 100mg | ||
| Each uncoated Tablet contain : | ||||
| Torsemide | IP | 5mg | ||
| Each film coated Tablet contain : | ||||
| Nifedipine | IP | 10mg | ||
|
334 |
Thiamine Tablets IP |
Each film coated Tablet contain : | ||
| Thiamine Hydrochloride | IP | 50mg | ||
| Each uncoated Tablet contain : | ||||
| Disulfiram | IP | 200mg | ||
| Each uncoated tablet contains: | ||||
| Furazolidone | IP | 100mg | ||
| Metronidazole | IP | 200mg | ||
| Each controlled release Tablet contains : | ||||
| Sodium valproate | IP | 333 mg | ||
| Valproic acid | IP | 145 mg | ||
| (Each together correspond to Sodium valporate IP 500mg) | ||||
|
338 |
Rabeprazole Sodium & Levosulpiride enteric coated tablets |
Each enteric coated tablet contains: | ||
| Rabeprazole Sodium | IP | 40mg | ||
| Levosulpiride | 75mg | |||
| Each enteric coated tablet contains: | ||||
| Esomeprazole Magnesium Trihydrate | IP | |||
| eq. to Esomeprazole | 20mg | |||
| Domperidone | IP | 15mg | ||
| Each film coated Tablet contains : | ||||
| Methylcobalamin | 1500mcg | |||
| L-Methylfolate Calcium | IP | 1mg | ||
| Pyridoxine 5-Phosphate | 5mg | |||
| Each film coated Tablet contains : | ||||
| Nebivolol Hcl | IP | 5mg | ||
| Telmisartan | IP | 40mg | ||
| Each uncoated Tablet contains: | ||||
| Etofylline | IP | 77mg | ||
| Theophylline (anhydrous) | IP | |||
| Eq. to Theophylline (Hydrate) | 23mg | |||
| Each film coated Tablet contains: | ||||
| Biotin | 5mg | |||
| Folic acid | IP | 5mg | ||
| Each uncoated Tablet contains: | ||||
| Fluconazole | IP | 150mg | ||
| Ivermectin | IP | 12mg | ||
| Each uncoated Tablet contains: | ||||
| Fluconazole | IP | 150mg | ||
| Ivermectin | IP | 6mg | ||
|
346 |
L-methyl folate calcium, pyridoxal-5-phosphate, Mecobalamin, cholecaciferol ,calcium citrate malate & vitamin K2 tablet |
Each film coated tablet contains: | ||
| L-methyl folate calcium | 0.5mg | |||
| Pyridoxal-5-phosphate | 1.5mg | |||
| Mecobalamin | IP | 1500mcg | ||
| Cholecaciferol | IP | 400 IU | ||
| Calcium citrate malate | IP | 250mg | ||
| Vitamin K2 | 10mcg | |||
| Each film coated tablet contains: | ||||
| Loperamide HCl | IP | 2mg | ||
| Lactic Acid Bacillus | 100 million spores | |||
| Each film coated tablet contains: | ||||
| Olmesartan Medoxomil | USP | 20mg | ||
| Amlodipine Besylate Chlorthalidone | IP | 5mg | ||
| Chlorthalidone | IP | 6.25mg | ||
| Each film coated tablet contains: | ||||
| Racecadotril | BP | 100mg | ||
| Ofloxacin | IP | 200mg | ||
| Each enteric coated tablet contains: | ||||
| Doxylamine Succinate | USP | 10mg | ||
| Pyridocine HCl | IP | 10mg | ||
|
351 |
Hyoscine Butylbromide & Mefenamic Acid film coated tablets |
Each film coated tablet contains: | ||
| Hyoscine Butylbromide | IP | 10mg | ||
| Mefenamic Acid | IP | 250mg | ||
| Each uncoated Tablet contains: | ||||
| Racecadotril | IP | 15mg | ||
| Saccharomyces boulardii 5.0 billion (Corresponding to 250mg of Yeast) | 282.5mg | |||
| Zinc Sulphate | ||||
| Eq. to elemental Zinc | IP | 7.5mg | ||
| Each film coated tablet contains: | ||||
| Diclofenac Potassium | BP | 50mg | ||
| Drotavarine Hydrochloride | IP | 80mg | ||
| Each film coated tablet contains: | ||||
| Amlodipine Besilate | IP | |||
| Eq. to Amlodipine | 5mg | |||
| Olmesartan medoxomil | IP | 40mg | ||
| Hydrochlorothiazide | IP | 12.5mg | ||
| Each uncoated tablet contains: | ||||
| Terbutaline sulphate Bromhexine HCl | IP | 2.5mg | ||
| Bromhexine HCl | IP | 8mg | ||
| Guaiphenesin | IP | 100mg | ||
| Each uncoated tablet contains: | ||||
| Metronidazole | 200mg | |||
| Furazolidone | 50mg | |||
| Dicyclomine Hcl | 10mg | |||
| Cefpodoxime proxetil & Dicloxacillin sodium tablets | Each film coated tablet contains: | |||
| Cefpodoxime proxetil | IP | |||
| Eq. to Cefpodoxime | 200mg | |||
| Dicloxacillin sodium (ER) | IP | 500mg | ||
| Each enteric coated bilayered tablet contains: | ||||
| Rabeprazole Sodium | IP | 20mg | ||
| Levosulpiride (SR) | IP | 75mg | ||
| Each uncoated dispersible tablet contains: | ||||
| Paracetamol | IP | 125mg | ||
| Ibuprofen | IP | 100mg | ||
| Each film coated tablet contains: | ||||
| Voglibose | 0.3mg | |||
| Metformin Hydrochloride | IP | 500mg | ||
| Each film coated tablet contains: | ||||
| Ubidecarenone | USP | 300mg | ||
| (Coenzyme Q10) | ||||
| Astaxanthin | 8mg | |||
| Each film coated tablet contains: | ||||
| Olmesartan Medoxomil Chlorthalidone | IP | 20mg | ||
| IP | 12.5mg | |||
| Each uncoated tablet contains: | ||||
| Amlodepine Besilate | IP | |||
| eq. to Amlodepine | 5mg | |||
| Atenolol | IP | 25mg | ||
|
364 |
Nystatin Tablets IP |
Each film coated tablet contains: | ||
| Nystatin | IP | 5000,00 units | ||
| Excipients | q.s | |||
| Each uncoated tablet contains: | ||||
| Griseofulvin | IP | 125mg | ||
| Excipients | q.s | |||
| Each uncoated tablet contains: | ||||
| Griseofulvin | ||||
| Excipients | 500mg | |||
| IP | q.s | |||
| Each film coated tablet contains: | ||||
| Levetiracetam | ||||
| Excipients | 250mg | |||
| IP | ||||
| q.s | ||||
| Each film coated tablet contains: | ||||
| Levetiracetam | IP | 500mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Levetiracetam | 750mg | |||
| Excipients | IP | q.s | ||
| 370 | Ornidazole Tablets IP | Each film coated tablet contains: | ||
| Ornidazole | IP | 500mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Gabapentin | ||||
| Excipients | 100mg | |||
| IP | ||||
| q.s | ||||
|
372 |
Chloroquine Phosphate Tablets IP |
Each film coated tablet contains: | ||
| Chloroquine Phosphate | IP | |||
| (eq. to 155mg of Chloroquine ) | 250mg | |||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Hydroxychloroquine Sulphate | IP | 200mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Etodolac | IP | 300mg | ||
| Excipients | q.s | |||
|
375 |
Metoprolol Succinate Extended-release Tablets IP |
Each film coated Extended-release tablet contains: | ||
| Metoprolol Succinate | IP | 23.75mg | ||
| Eq. to Metoprolol Tartrate | 25mg | |||
| Excipients | q.s | |||
|
376 |
Cilnidipine Tablets IP |
Each film coated tablet contains: | ||
| Cilnidipine | IP | 10mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Ferrous Ascorbate | ||||
| Eq. to elemental Iron | 100mg | |||
| Folic acid | IP | 1.5mg | ||
| Methylcobalamin | IP | 1500mcg | ||
| Excipients | q.s. | |||
|
378 |
Chlordiazepoxide, |
Each film coated tablet contains: | ||
| Chlordiazepoxide | IP | 5mg | ||
| Clidinium Bromide | USP | 2.50mg | ||
| Dicyclomine Hydrochloride | IP | 10mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Citicoline Sodium | ||||
| eq. to Citicoline | IP | 500mg | ||
| Mecobalamin | IP | 750mcg | ||
| Excipients | q.s | |||
|
380 |
Montelukast & Fexofenadine Chewable Tablets |
Each uncoated chewable tablet contains: | ||
| Montelukast Sodium | IP | |||
| Eq. to Montelukast | 10mg | |||
| Fexofenadine Hydrochloride | IP | 120mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Norfloxacin | IP | 400mg | ||
| Tinidazole | IP | 600mg | ||
| q.s | ||||
| Each uncoated Tablet contain : | ||||
| Glimepiride | IP | 1mg | ||
| Metformin Hydrochloride | IP | 850mg | ||
| (as sustained release form) | ||||
|
383 |
Glimepiride & Metformin Tablets |
Each uncoated Tablet contain : | ||
| Glimepiride | IP | 2mg | ||
| Metformin Hydrochloride | IP | 850mg | ||
| (as sustained release form) | ||||
|
384 |
Glimepiride & Metformin Tablets |
Each uncoated Tablet contains: | ||
| Glimepiride | IP | 3mg | ||
| Metformin Hydrochloride | IP | 850mg | ||
| (as sustained release form) | ||||
|
385 |
Glimepiride & Metformin Tablets |
Each uncoated Tablet contain : | ||
| Glimepiride | IP | 3mg | ||
| Metformin Hydrochloride | IP | 1000mg | ||
| (as sustained release form) | ||||
|
386 |
Glimepiride & Metformin Tablets |
Each uncoated Tablet contain : | ||
| Glimepiride | IP | 4mg | ||
| Metformin Hydrochloride | IP | 1000mg | ||
| (as sustained release form) | ||||
| Each film coated tablet contains: | ||||
| Voglibose | 0.3mg | |||
| Metformin Hydrochloride | IP | 500mg | ||
| Each sustained release Tablet contains: | ||||
| Etofylline | BP | 231mg | ||
| Theophylline anhydrous | IP | |||
| eq. to Theophylline hydrate | 69mg | |||
| Salbutamol Sulphate | IP | |||
| eq. to Salbutamol | 4mg | |||
| Each Film Coated Tablet contains: | ||||
| Ivermectin | IP | 12mg | ||
|
390 |
Etodolac & Thiocolchicoside Tablets |
Each film coated tablet contains: | ||
| Etodolac | IP | 300mg | ||
| Thiocolchicoside | IP | 4mg | ||
| Excipients | ||||
| Each film coated Extended-release tablet contains: | ||||
| Etodolac | IP | 500mg | ||
| Excipients | q.s | |||
| Each uncoated tablet contains: | ||||
| Fluconazole | IP | 400mg | ||
| Excipients | q.s. | |||
| Each film coated tablet contains: | ||||
| Deflazacort | ||||
| Excipients | 12mg | |||
| q.s | ||||
| Each film coated tablet contains: | ||||
| Aceclofenac | 100mg | |||
| Tizanidine Hydrochloride | IP | 2mg | ||
| Excipients | q.s | |||
| Each enteric coated tablet contains: | ||||
| 1,00,000 armour units of enzymatic activity supplied by a purified concentrate which has specifi Trypsin & Chymotrypsin activity in a ratio approximately six to one | ||||
|
396 |
Aceclofenac (SR) & Pregabalin (SR) Tablets |
Each uncoated Bilayer Sustained release tablet contains: | ||
| Aceclofenac | IP | 200mg | ||
| Pregabalin | IP | 75mg | ||
| Excipients | q.s | |||
|
397 |
Metoprolol Succinate Extend Release & Telmisartan Tablets |
Each film coated tablet contains: | ||
| Metoprolol Succinate | IP | 23.75mg | ||
| Eq. to Metoprolol Tartrate | 25mg | |||
| Telmisartan | IP | 40mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Acebrophylline | 100mg | |||
| N-Acetylcysteine | BP | 600mg | ||
| Excipients | q.s. | |||
| Each uncoated tablet contains: | ||||
| Metformin Hydrochloride (As sustained release) | IP | 1000mg | ||
| Glimepiride | IP | 3mg | ||
| Excipients | ||||
| Each film coated tablet contains: | ||||
| Tapentadol HCl | ||||
| Eq. to Tepentadol | IP | 100mg | ||
| Excipients | q.s | |||
| Azithromycin & Lactic Acid Bacillus Tablets IP | Each film coated tablet contains: | |||
| Azithromycin Dihydrate | ||||
| Eq.to Anhydrous Azithromycin | IP | 250mg | ||
| Lactic Acid Bacillus | 60Million spores | |||
| Each film coated tablet contains: | ||||
| Azithromycin Dihydrate | ||||
| Eq.to Anhydrous Azithromycin | IP | 500mg | ||
| Lactic Acid Bacillus | 60Million spores | |||
| Each uncoated Bilayer tablet contains: | ||||
| Myo-Inositol | BP | 600mg | ||
| Metformin Hydrochloride | IP | 500mg | ||
| (As sustained-release) | ||||
| Excipients | q.s | |||
|
404 |
Paracetamol, Phenylephrine HCl |
Each uncoated tablet contains: | ||
| Paracetamol | IP | 500mg | ||
| Phenylephrine HCl | IP | 5mg | ||
| Levocetirizine HCl | IP | 5mg | ||
| Excipients | q.s | |||
|
405 |
Trypsin, Bromelain, Rutoside & Aceclofenac Tablets |
Each film coated tablet contains: | ||
| Trypsin | BP | 48mg | ||
| Bromelain | 90mg | |||
| Rutoside Trihydrate | BP | 100mg | ||
| Aceclofenac | IP | 100mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Ferrous Bis-Glycinate | ||||
| Eq. to Elemental Iron | 60mg | |||
| Zinc Bis- Glycinate | ||||
| Eq. to Elemental Zinc | 15mg | |||
| Folic Acid | IP | 1mg | ||
| Mecobalamin | IP | 500mcg | ||
| Excipients | q.s | |||
|
407 |
Aceclofenac, Paracetamol, Trypsin & Chymotrypsin Tablets |
Each film coated tablet contain: | ||
| Aceclofenac | IP | 100mg | ||
| Paracetamol | IP | 325mg | ||
| Proteolytic enzyme Trypsin and Chymotrypsin in the ratio of 6:1 and provides enzymes activity | 50,000AU | |||
| Excipients | q.s | |||
|
408 |
Etoricoxib and Paracetamol Tablets |
Each film coated tablet contain: | ||
| Etoricoxib | IP | 60mg | ||
| Paracetamol | IP | 325mg | ||
| Excipients | q.s | |||
| Each uncoated Dispersible tablet contain: | ||||
| Ketorolac Tromethamine Excipients | IP | 10mg | ||
| Each film coated tablet contain: | ||||
| Gabapentin | ||||
| Nortriptyline Hydrochloride | 400mg | |||
| eq. to Nortriptyline | IP | |||
| Excipients | ||||
| IP | 10mg | |||
| q.s | ||||
| Each uncoated Orally Disintegrating tablet contains: | ||||
| Lansoprazole | IP | 15mg | ||
| Excipients | q.s | |||
| Each film coated tablet contains: | ||||
| Amoxycillin Trihydrate | IP | |||
| Eq. to Amoxycillin (anhydrous) | 500mg | |||
| Potassium Clavulanate Diluted | IP | |||
| Eq. to Clavulanic Acid | 125 mg | |||
| Lactic Acid Bacillus | 60 million spores | |||
| Each film coated tablet contain: | ||||
| Teneligliptin | IP | 10mg | ||
| Each uncoated tablet contain: | ||||
| Mefenamic Acid | IP | 50mg | ||
| Paracetamol | IP | 125mg | ||
| Each film coated tablet contain: | ||||
| Gliclazide | IP | 60mg | ||
| Metformin HCl | IP | 500mg | ||
| (as sustained release form) | ||||
| Cefixime (SR) & Moxifloxacin (SR)Tablets | Each sustained release tablet contain: | |||
| Cefixime Trihydrate Eq.to Cefixime | IP | 400mg | ||
| Moxifloxacin HCl | IP | |||
| Eq.to Moxifloxacin | 400mg | |||
